Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.100
+0.210 (11.11%)
At close: Aug 28, 2025, 4:00 PM
2.010
-0.090 (-4.28%)
After-hours: Aug 28, 2025, 5:51 PM EDT
Alaunos Therapeutics Market Cap
Alaunos Therapeutics has a market cap or net worth of $4.63 million as of August 28, 2025. Its market cap has increased by 15.80% in one year.
Market Cap
4.63M
Enterprise Value
1.51M
1-Year Change
15.80%
Ranking
Category
Stock Price
$2.10
Market Cap Chart
Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $4.63M, a decrease of -93.93%. That is a compound annual growth rate of -13.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 4.10M | 32.26% |
| Dec 31, 2024 | 3.10M | -81.76% |
| Dec 29, 2023 | 17.00M | -87.88% |
| Dec 30, 2022 | 140.30M | -40.45% |
| Dec 31, 2021 | 235.60M | -56.37% |
| Dec 31, 2020 | 540.00M | -36.81% |
| Dec 31, 2019 | 854.50M | 220.88% |
| Dec 31, 2018 | 266.30M | -54.69% |
| Dec 29, 2017 | 587.70M | -16.61% |
| Dec 30, 2016 | 704.80M | -35.20% |
| Dec 31, 2015 | 1.09B | 108.89% |
| Dec 31, 2014 | 520.70M | 43.36% |
| Dec 31, 2013 | 363.20M | 9.66% |
| Dec 31, 2012 | 331.20M | 9.71% |
| Dec 30, 2011 | 301.90M | 33.41% |
| Dec 31, 2010 | 226.30M | 198.94% |
| Dec 31, 2009 | 75.70M | 510.48% |
| Dec 31, 2008 | 12.40M | -83.49% |
| Dec 31, 2007 | 75.10M | -17.56% |
| Dec 29, 2006 | 91.10M | 19.40% |
| Sep 22, 2006 | 76.30M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |